These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31768956)

  • 1. Occurrence of 40 pharmaceutically active compounds in hospital and urban wastewaters and their contribution to Mahdia coastal seawater contamination.
    Afsa S; Hamden K; Lara Martin PA; Mansour HB
    Environ Sci Pollut Res Int; 2020 Jan; 27(2):1941-1955. PubMed ID: 31768956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of multiclass pharmaceutical active compounds (PhACs) in hospital WWTP influent and effluent samples by UHPLC-Orbitrap MS: Temporal variation, removals and environmental risk assessment.
    Kosma CI; Kapsi MG; Konstas PG; Trantopoulos EP; Boti VI; Konstantinou IK; Albanis TA
    Environ Res; 2020 Dec; 191():110152. PubMed ID: 32877707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.
    Paíga P; Correia M; Fernandes MJ; Silva A; Carvalho M; Vieira J; Jorge S; Silva JG; Freire C; Delerue-Matos C
    Sci Total Environ; 2019 Jan; 648():582-600. PubMed ID: 30121536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
    Kosma CI; Lambropoulou DA; Albanis TA
    Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals.
    Santos LH; Gros M; Rodriguez-Mozaz S; Delerue-Matos C; Pena A; Barceló D; Montenegro MC
    Sci Total Environ; 2013 Sep; 461-462():302-16. PubMed ID: 23732224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
    Ulvi A; Aydın S; Aydın ME
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceuticals as chemical markers of wastewater contamination in the vulnerable area of the Ebro Delta (Spain).
    Čelić M; Gros M; Farré M; Barceló D; Petrović M
    Sci Total Environ; 2019 Feb; 652():952-963. PubMed ID: 30380500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of selected pharmaceuticals in wastewater treatment plants of Tuscany: An effect-based approach to evaluate the potential environmental impact.
    Palli L; Spina F; Varese GC; Vincenzi M; Aragno M; Arcangeli G; Mucci N; Santianni D; Caffaz S; Gori R
    Int J Hyg Environ Health; 2019 May; 222(4):717-725. PubMed ID: 31101503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of pharmaceuticals, hazard assessment and ecotoxicological evaluation of wastewater treatment plants in Costa Rica.
    Ramírez-Morales D; Masís-Mora M; Montiel-Mora JR; Cambronero-Heinrichs JC; Briceño-Guevara S; Rojas-Sánchez CE; Méndez-Rivera M; Arias-Mora V; Tormo-Budowski R; Brenes-Alfaro L; Rodríguez-Rodríguez CE
    Sci Total Environ; 2020 Dec; 746():141200. PubMed ID: 32771760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of pharmaceuticals and personal care products in effluent-dominated Saudi Arabian coastal waters of the Red Sea.
    Ali AM; Rønning HT; Alarif W; Kallenborn R; Al-Lihaibi SS
    Chemosphere; 2017 May; 175():505-513. PubMed ID: 28249192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental risk assessment of selected pharmaceuticals in hospital wastewater in nothern Vietnam.
    Hoang ATP; Do MC; Kim KW
    Chemosphere; 2024 May; 356():141973. PubMed ID: 38608777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of pharmaceuticals in surface and wastewater from Cuernavaca, Morelos, Mexico: Occurrence and environmental risk assessment.
    Rivera-Jaimes JA; Postigo C; Melgoza-Alemán RM; Aceña J; Barceló D; López de Alda M
    Sci Total Environ; 2018 Feb; 613-614():1263-1274. PubMed ID: 28962074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard.
    Mendoza A; Aceña J; Pérez S; López de Alda M; Barceló D; Gil A; Valcárcel Y
    Environ Res; 2015 Jul; 140():225-41. PubMed ID: 25880605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in Central Greece.
    Papageorgiou M; Kosma C; Lambropoulou D
    Sci Total Environ; 2016 Feb; 543(Pt A):547-569. PubMed ID: 26613513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and spatial distribution of 158 pharmaceuticals, drugs of abuse and related metabolites in offshore seawater.
    Alygizakis NA; Gago-Ferrero P; Borova VL; Pavlidou A; Hatzianestis I; Thomaidis NS
    Sci Total Environ; 2016 Jan; 541():1097-1105. PubMed ID: 26473711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir Area.
    Yan Q; Gao X; Chen YP; Peng XY; Zhang YX; Gan XM; Zi CF; Guo JS
    Sci Total Environ; 2014 Feb; 470-471():618-30. PubMed ID: 24176710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS.
    Oliveira TS; Murphy M; Mendola N; Wong V; Carlson D; Waring L
    Sci Total Environ; 2015 Jun; 518-519():459-78. PubMed ID: 25777952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of non-steroidal anti-inflammatory drugs in Tehran source water, municipal and hospital wastewaters, and their ecotoxicological risk assessment.
    Eslami A; Amini MM; Yazdanbakhsh AR; Rastkari N; Mohseni-Bandpei A; Nasseri S; Piroti E; Asadi A
    Environ Monit Assess; 2015 Dec; 187(12):734. PubMed ID: 26553436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence, distribution and environmental risk of pharmaceutically active compounds (PhACs) in coastal and ocean waters from the Gulf of Cadiz (SW Spain).
    Biel-Maeso M; Baena-Nogueras RM; Corada-Fernández C; Lara-Martín PA
    Sci Total Environ; 2018 Jan; 612():649-659. PubMed ID: 28866393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration evolution of pharmaceutically active compounds in raw urban and industrial wastewater.
    Camacho-Muñoz D; Martín J; Santos JL; Aparicio I; Alonso E
    Chemosphere; 2014 Sep; 111():70-9. PubMed ID: 24997902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.